C6orf128 Activators
Chemical activators of C6orf128 engage in various molecular interactions to initiate a cascade of intracellular events leading to the protein's activation. Forskolin, for instance, directly targets adenylate cyclase, which catalyzes the conversion of ATP to cyclic AMP (cAMP). The increase in cAMP levels subsequently activates protein kinase A (PKA). Once activated, PKA phosphorylates different proteins, potentially including C6orf128, thereby switching on its activity. Similarly, 8-Bromo-cAMP, a cAMP analog, permeates the cell membrane and activates PKA, following the same pathway to influence the phosphorylation status of C6orf128. On another front, ionomycin facilitates the influx of calcium ions into the cell, increasing intracellular calcium, which can activate calmodulin-dependent kinases known to phosphorylate a range of proteins. This elevation in calcium levels can similarly result from the action of thapsigargin, which disrupts calcium sequestration by inhibiting the SERCA pump, leading to a rise in cytosolic calcium and subsequent activation of kinases such as CAMKII that may target C6orf128.
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which then phosphorylates various substrates in its signaling pathway, including potentially C6orf128. Calyculin A and Okadaic Acid, inhibitors of protein phosphatases PP1 and PP2A, prevent the dephosphorylation of proteins, resulting in a net increase in the phosphorylated state of proteins within the cell, which can include C6orf128. Anisomycin, through its activation of stress-activated protein kinases such as JNK, can lead to the phosphorylation of a broad spectrum of proteins, among which C6orf128 may be included. Spermine, known to modulate ion channels and kinases, can initiate a sequence of signaling events culminating in the phosphorylation of C6orf128. Zaprinast and Spermine NONOate, by inhibiting PDE5 and releasing nitric oxide respectively, both raise cGMP levels, which activate PKG. PKG, in turn, can phosphorylate proteins involved in the cGMP pathway, including C6orf128. Lastly, Bisindolylmaleimide I, although typically an inhibitor of PKC, can under certain conditions activate PKC, potentially leading to the phosphorylation and activation of C6orf128, if it is within PKC's signal transduction reach.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, increasing intracellular calcium concentrations. This can activate calmodulin-dependent kinases, which could then phosphorylate and activate C6orf128, as calcium signaling is a common upstream activator of various proteins. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the SERCA pump, leading to increased cytosolic calcium levels. This in turn activates downstream kinases such as CAMKII, which could phosphorylate and lead to the activation of C6orf128 within the calcium signaling pathway. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate substrates within its signaling cascade. Since PKC can activate numerous proteins, this could include C6orf128 if it is a substrate for PKC in any of its signaling pathways. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. Activated PKA can phosphorylate and activate proteins within its signaling cascade, potentially including C6orf128 if it is part of the PKA pathway. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels. This could result in the activation of C6orf128 if dephosphorylation by these phosphatases keeps C6orf128 inactive under basal conditions. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A, similar to Calyculin A, leading to enhanced phosphorylation within cells. This could activate C6orf128 if the protein is normally regulated by dephosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases such as JNK. JNK can phosphorylate a wide array of substrates, possibly including C6orf128, leading to its activation as part of stress response signaling pathways. | ||||||
Spermine | 71-44-3 | sc-212953A sc-212953 sc-212953B sc-212953C | 1 g 5 g 25 g 100 g | $61.00 $196.00 $277.00 $901.00 | 1 | |
Spermine can modulate ion channels and indirectly activate kinases. This could lead to the activation of C6orf128 through signaling pathways that are sensitive to changes in ion concentrations and kinase activity. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterase type 5 (PDE5), leading to increased cGMP levels, which can activate PKG. If C6orf128 is a substrate of PKG or is involved in the cGMP pathway, this would result in its activation. | ||||||
Spermine NONOate | 136587-13-8 | sc-202816 sc-202816A | 5 mg 25 mg | $53.00 $196.00 | 5 | |
Spermine NONOate releases nitric oxide, which can increase cGMP levels by activating guanylate cyclase. Elevated cGMP can then activate PKG, which in turn could phosphorylate and activate C6orf128 if it is part of the NO/cGMP signaling pathway. | ||||||